Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study

Cancer Epidemiology

Volumn 35, Issue 5, 2011, Pages 448-452

  Conroy, Shannon M ^a   Pagano, Ian ^a   Kolonel, Laurence N ^a   Maskarinec, Gertraud ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Estrogen receptor; Mammographic density; Progesterone receptor; Tumor characteristics

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DENSITY; ETHNICITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRADUCTAL CARCINOMA; JAPANESE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HAWAII; HUMANS; MALE; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SURVIVAL RATE;

EID: 79960050465     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.11.011     Document Type: Article

References (31)

1. McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(6):1159-1169.
2. Maskarinec G., Pagano I., Lurie G., Wilkens L.R., Kolonel L.N. Mammographic density and breast cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 2005, 162(8):743-752.
3. Ursin G., Ma H., Wu A.H., Bernstein L., Salane M., Parisky Y.R., et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003, 12(4):332-338.
4. Byrne C., Schairer C., Wolfe J., Parekh N., Salane M., Brinton L.A., et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87(21):1622-1629.
5. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354(3):270-282.
6. Lange C.A., Sartorius C.A., Abdel-Hafiz H., Spillman M.A., Horwitz K.B., Jacobsen B.M. Progesterone receptor action: translating studies in breast cancer models to clinical insights. Adv Exp Med Biol 2008, 630:94-111.
7. Colditz G.A., Rosner B.A., Chen W.Y., Holmes M.D., Hankinson S.E. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004, 96(3):218-228.
8. Dunnwald L.K., Rossing M.A., Li C.I. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007, 9(1):R6.
9. Martin L.J., Boyd N.F. Mammographic density potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008, 10(1):201.
10. Vachon C.M., Kuni C.C., Anderson K., Anderson V.E., Sellers T.A. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000, 11(7):653-662.
11. Ding J., Warren R., Girling A., Thompson D., Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 2010, 16(3):279-289.
12. Ziv E., Tice J., Smith-Bindman R., Shepherd J., Cummings S., Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004, 13(12):2090-2095.
13. Aiello E.J., Buist D.S., White E., Porter P.L. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 2005, 14(3):662-668.
14. Ghosh K., Brandt K.R., Sellers T.A., Reynolds C., Scott C.G., Maloney S.D., et al. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17(4):872-879.
15. Ma H., Luo J., Press M.F., Wang Y., Bernstein L., Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18(2):479-485.
16. Kolonel L.N., Henderson B.E., Hankin J.H., Nomura A.M., Wilkens L.R., Pike M.C., et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000, 151(4):346-357.
17. Gill J.K., Maskarinec G., Pagano I., Kolonel L.N. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 2006, 8(3):R30.
18. Byng J.W., Boyd N.F., Fishell E., Jong R.A., Yaffe M.J. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39(10):1629-1638.
19. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley, New York. 2nd ed.
20. Pike M.C., Kolonel L.N., Henderson B.E., Wilkens L.R., Hankin J.H., Feigelson H.S., et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 2002, 11(9):795-800.
21. Boyd N.F., Lockwood G.A., Martin L.J., Knight J.A., Byng J.W., Yaffe M.J., et al. Mammographic densities and breast cancer risk. Breast Dis 1998, 10(3-4):113-126.
22. Boyd N.F., Stone J., Martin L.J., Jong R., Fishell E., Yaffe M., et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002, 87(8):876-882.
23. Tamimi R.M., Hankinson S.E., Colditz G.A., Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005, 14(11 Pt 1):2641-2647.
24. van Duijnhoven F.J., Bezemer I.D., Peeters P.H., Roest M., Uitterlinden A.G., Grobbee D.E., et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev 2005, 14(11 Pt 1):2655-2660.
25. Martin K.E., Helvie M.A., Zhou C., Roubidoux M.A., Bailey J.E., Paramagul C., et al. Mammographic density measured with quantitative computer-aided method: comparison with radiologists' estimates and BI-RADS categories. Radiology 2006, 240(3):656-665.
26. Ross J.S., Fletcher J.A. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist 1998, 3(4):237-252.
27. Ciatto S., Visioli C., Paci E., Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 2004, 90(2):393-396.
28. Mandelson M.T., Oestreicher N., Porter P.L., White D., Finder C.A., Taplin S.H., et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000, 92(13):1081-1087.
29. Collett K., Stefansson I.M., Eide J., Braaten A., Wang H., Eide G.E., et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1108-1112.
30. Dawson S.J., Duffy S.W., Blows F.M., Driver K.E., Provenzano E., LeQuesne J., et al. Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. Br J Cancer 2009, 101(8):1338-1344.
31. Palka I., Kelemen G., Ormandi K., Lazar G., Nyari T., Thurzo L., et al. Tumor characteristics in screen-detected and symptomatic breast cancers. Pathol Oncol Res 2008, 14(2):161-167.